News

EMD Serono has announced that it will open a research site in Cambridge, Massachusetts to support its research function. According to the company, the Cambridge laboratory space will

Repligen, a biopharmaceutical company, has exclusively licensed worldwide rights for the use of uridine in the treatment of patients with bipolar disorder from McLean Hospital, the psychiatric facility

Novartis has received FDA approval for Afinitor tablets for patients with advanced renal cell carcinoma after failure of treatment with Sutent or Nexavar. The approval is based on

According to Edwards Lifesciences, the new software draws upon analysis and a broader patient database to enable the FloTrac system to automatically and accurately adjust to the radical

Cardima, a medical device company, has received CE Mark approval for its Surgical Ablation Probe with stabilization sheath. All components of the Cardima Surgical Ablation system are now

The patent application is for a novel taste-masking formulation which CyDex has developed. CyDex’s Captisol has been combined with Sertraline. Key benefits of this formulation by CyDex are:

The newly allowed claims include subject matter covering methods of using a controlled-release oral dosage form of minocycline to treat acne. Solodyn has one issued US patent, which

Cell Therapeutics (CTI) previously received approximately $6.5 million on March 2, 2009, related to this transaction, and the remaining $3.5 million, subject to adjustments for expenses and revenues,

In October 2008, OctoPlus announced a strategic focus on developing controlled release versions of existing or new drugs for clients, in addition to providing general formulation development and